Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease

BACKGROUND AND PURPOSE: To assess the long-term safety and efficacy of pramipexole as a once-daily (q.d.) extended-release oral formulation in early or advanced Parkinson's disease (PD). METHODS: In two double-blind (DB) studies of early PD and one of advanced PD, active-treatment arms received...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, R A, Schapira, A H V, Barone, P, Mizuno, Y, Rascol, O, Busse, M, Debieuvre, C, Fraessdorf, M, Poewe, W, Pramipexole ER Studies Group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282380/
https://www.ncbi.nlm.nih.gov/pubmed/24834511
http://dx.doi.org/10.1111/ene.12375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282380/
https://www.ncbi.nlm.nih.gov/pubmed/24834511
http://dx.doi.org/10.1111/ene.12375

Ejemplares similares